{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T14:06:05Z","timestamp":1770473165322,"version":"3.49.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,7]]},"DOI":"10.1093\/jac\/44.1.71","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:24:55Z","timestamp":1027722295000},"page":"71-76","source":"Crossref","is-referenced-by-count":53,"title":["Flow cytometric assessment of amphotericin B susceptibility in Leishmania infantumisolates from patients with visceral leishmaniasis"],"prefix":"10.1093","volume":"44","author":[{"given":"C.","family":"Di Giorgio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Faraut-Gambarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Minodier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gasquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Dumon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,7]]},"reference":[{"key":"key\n\t\t\t\t20170411034153_R1","doi-asserted-by":"crossref","unstructured":"Berman, J. D. (1997). Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clinical Infectious Diseases24, 684\u2013703.","DOI":"10.1093\/clind\/24.4.684"},{"key":"key\n\t\t\t\t20170411034153_R2","doi-asserted-by":"crossref","unstructured":"Herwaldt, B. L. & Berman, J. D. (1992). Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. American Journal of Tropical Medicine and Hygiene46, 296\u2013306.","DOI":"10.4269\/ajtmh.1992.46.296"},{"key":"key\n\t\t\t\t20170411034153_R3","doi-asserted-by":"crossref","unstructured":"Faraut-Gambarelli, F., Piarroux, R., Deniau, M., Giusiano, B., Marty, P., Michel, G. et al.(1997). In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrobial Agents and Chemotherapy41, 827\u201330.","DOI":"10.1128\/AAC.41.4.827"},{"key":"key\n\t\t\t\t20170411034153_R4","doi-asserted-by":"crossref","unstructured":"Croft, S. L., Davidson, R. N. & Thornton, E. A. (1991). Liposomal amphotericin B in the treatment of visceral leishmaniasis. Journal of Antimicrobial Chemotherapy28, Suppl. B, 111\u201318.","DOI":"10.1093\/jac\/28.suppl_B.111"},{"key":"key\n\t\t\t\t20170411034153_R5","doi-asserted-by":"crossref","unstructured":"Davidson, R. N., Croft, S. L., Scott, A., Maini, M., Moody, A. H. & Bryceson, A. D. (1991). Liposomal amphotericin B in drug resistant visceral leishmaniasis. Lancet337, 1061\u20132.","DOI":"10.1016\/0140-6736(91)91708-3"},{"key":"key\n\t\t\t\t20170411034153_R6","doi-asserted-by":"crossref","unstructured":"Davidson, R. N. & Russo, R. (1994). Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B. Clinical Infectious Diseases19, 560.","DOI":"10.1093\/clinids\/19.3.560"},{"key":"key\n\t\t\t\t20170411034153_R7","doi-asserted-by":"crossref","unstructured":"Durand, R., Paul, M., Pratlong, F., Rivollet, D., Dubreuil-Lemaire, M. L., Houin, R. et al. (1998). Leishmania infantum: lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis. Antimicrobial Agents and Chemotherapy42, 2141\u20133.","DOI":"10.1128\/AAC.42.8.2141"},{"key":"key\n\t\t\t\t20170411034153_R8","doi-asserted-by":"crossref","unstructured":"Mbongo, N., Loiseau, P. M., Billion, M. A. & Robert-Gero, M. (1998). Mechanism of amphotericin B resistance in Leishmania donovani promastigotes. Antimicrobial Agents and Chemotherapy42, 352\u20137.","DOI":"10.1128\/AAC.42.2.352"},{"key":"key\n\t\t\t\t20170411034153_R9","doi-asserted-by":"crossref","unstructured":"Azas, N., Di Giorgio, C., Delmas, F., Gasquet, M. & Timon-David, P. (1997). Assessment of amphotericin B susceptibility in Leishmania infantum promastigotes by flow cytometric membrane potential assay. Cytometry28, 165\u20138.","DOI":"10.1002\/(SICI)1097-0320(19970601)28:2<165::AID-CYTO10>3.0.CO;2-O"},{"key":"key\n\t\t\t\t20170411034153_R10","doi-asserted-by":"crossref","unstructured":"Peyron, F., Favel, A., Guiraud-Dauriac, H., El Mzibri, M., Chastin, C., Dumenil, G. et al. (1997). Evaluation of a flow cytofluorometric method for rapid determination of amphotericin B susceptibility of yeasts isolates. Antimicrobial Agents and Chemotherapy41, 1537\u201340.","DOI":"10.1128\/AAC.41.7.1537"},{"key":"key\n\t\t\t\t20170411034153_R11","doi-asserted-by":"crossref","unstructured":"Ordonez, J. V. & Wehman, N. M. (1993). Rapid flow cytometric antibiotic susceptibility assay for Staphylococcus aureus.Cytometry14, 811\u201318.","DOI":"10.1002\/cyto.990140714"},{"key":"key\n\t\t\t\t20170411034153_R12","doi-asserted-by":"crossref","unstructured":"Ogunkolade, B. W., Colomb-Valet, I., Monjour, L., Rhodes-Feuillette, A., Abita, J. P. & Frommel, D. (1990). Interactions between the human monocytic leukaemia THP1 cell line and Old and New World species of Leishmania.Acta Tropica47, 171\u20136.","DOI":"10.1016\/0001-706X(90)90023-S"},{"key":"key\n\t\t\t\t20170411034153_R13","unstructured":"Lazanas, M. C., Tsekes, G. A., Papandreou, S., Harhalakis, N., Scandali, A., Nikiforakis, E. et al. (1991). Liposomal amphotericin B for leishmaniasis treatment of AIDS patients unresponsive to antimonium compounds. AIDS7, 1018\u201319."},{"key":"key\n\t\t\t\t20170411034153_R14","unstructured":"Sen Gupta, P. C. (1953). Chemotherapy of leishmanial diseases: a resume of recent researches. Indian Medical Gazette88, 20\u201335."},{"key":"key\n\t\t\t\t20170411034153_R15","doi-asserted-by":"crossref","unstructured":"Cascio, A., Gradoni, L., Scarlata, F., Gamiccia, M., Giordano S., Russo, R. et al. (1997). Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy. American Journal of Tropical Medicine and Hygiene57, 75\u20138.","DOI":"10.4269\/ajtmh.1997.57.75"},{"key":"key\n\t\t\t\t20170411034153_R16","doi-asserted-by":"crossref","unstructured":"di Martino, L., Davidson, R. N., Giacchino, R., Scotti, S., Raimondi, F., Castagnola, E. et al. (1997). Treatment of visceral leishmaniasis in children with liposomal amphotericin B. Journal of Pediatrics13, 272\u20137.","DOI":"10.1016\/S0022-3476(97)70165-3"},{"key":"key\n\t\t\t\t20170411034153_R17","unstructured":"Matheron, S., Cabie, A., Parquin, F., Mayaud, C., Roux, P., Antoine, M. et al. (1992). Visceral leishmaniasis in HIV infection: unusual presentation with pleuropulmonary involvements, and effect of secondary prophylaxis. AIDS6, 238\u201340."},{"key":"key\n\t\t\t\t20170411034153_R18","doi-asserted-by":"crossref","unstructured":"Paul, M., Durand, R., Fessi, H., Rivollet, D., Houin, R., Astier, A. et al. (1997). Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model. Antimicrobial Agents and Chemotherapy41, 1731\u20134.","DOI":"10.1128\/AAC.41.8.1731"},{"key":"key\n\t\t\t\t20170411034153_R19","doi-asserted-by":"crossref","unstructured":"Mullen, A. B., Carter, K. C. & Baillie, A. J. (1997). Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis. Antimicrobial Agents and Chemotherapy41, 2089\u201392.","DOI":"10.1128\/AAC.41.10.2089"},{"key":"key\n\t\t\t\t20170411034153_R20","doi-asserted-by":"crossref","unstructured":"Coukell, A. J. & Brogden, R. N. (1998). Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis. Drugs55, 585\u2013612.","DOI":"10.2165\/00003495-199855040-00008"},{"key":"key\n\t\t\t\t20170411034153_R21","doi-asserted-by":"crossref","unstructured":"Brajtburg, J., Powderly, W. G., Kobayashi, G. S. & Medoff, G. (1990). Amphotericin B: current understanding of mechanisms of action. Antimicrobial Agents and Chemotherapy34, 183\u20138.","DOI":"10.1128\/AAC.34.2.183"},{"key":"key\n\t\t\t\t20170411034153_R22","doi-asserted-by":"crossref","unstructured":"Sokol-Anderson, M., Sligh, J. E., Elberg, S., Brajtburg, J., Kobayashi, G. S. & Medoff, G. (1988). Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin B. Antimicrobial Agents and Chemotherapy32, 702\u20135.","DOI":"10.1128\/AAC.32.5.702"},{"key":"key\n\t\t\t\t20170411034153_R23","doi-asserted-by":"crossref","unstructured":"Beggs, W. H. (1994). Physicochemical cell damage in relation to lethal amphotericin B action. Antimicrobial Agents and Chemotherapy38, 363\u20134.","DOI":"10.1128\/AAC.38.2.363"},{"key":"key\n\t\t\t\t20170411034153_R24","doi-asserted-by":"crossref","unstructured":"Ramos, H., Valdivieso, E., Gamargo, M., Dagger, F. & Cohen, B. E. (1996). Amphotericin B kills unicellular leishmanias by forming aqueous pores permeable to small cations and anions. Journal of Membrane Biology152, 65\u201375.","DOI":"10.1007\/s002329900086"},{"key":"key\n\t\t\t\t20170411034153_R25","doi-asserted-by":"crossref","unstructured":"Callahan, H. L., Portal, A. C., Devereaux, R. & Grogl, M. (1997). An axenic amastigote system for drug screening. Antimicrobial Agents and Chemotherapy41, 818\u201322.","DOI":"10.1128\/AAC.41.4.818"},{"key":"key\n\t\t\t\t20170411034153_R26","doi-asserted-by":"crossref","unstructured":"Mozaffarian, N., Berman, J. W. & Casadevall, A. (1997). Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B. Antimicrobial Agents and Chemotherapy41, 1825\u201329.","DOI":"10.1128\/AAC.41.8.1825"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/44\/1\/71\/13056863\/JAC44171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T15:58:43Z","timestamp":1621267123000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/44.1.71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1999,7]]},"published-print":{"date-parts":[[1999,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/44.1.71","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[1999,7]]}}}